Vasodilation Therapy
Vasodilation Therapy - Related Videos
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
0 Views •
Cited by 165 •
2010
A noninvasive procedure to assess endothelial function is demonstrated using the Endo-PAT 2000.
08:09
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
0 Views •
Cited by 1 •
2017
We describe the isolation of cardiac extracellular matrix from C57Bl/6J control mice, tight-skin mice, and tight-skin mice treated with the IRF5 inhibitory peptide. We also describe the vasodilation studies on the isolated vessels from C57Bl/6J, tight-skin mice and tight-skin mice treated with the IRF5 inhibitory peptide.
01:23
Antihypertensive Drugs: Vasodilators
0 Views •
2024
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:26
Group Therapy
0 Views •
2025
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
08:42
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
0 Views •
Cited by 42 •
2014
Endothelial dysfunction is associated with numerous disease states and is predictive of adverse cardiovascular events in humans. Flow-mediated vasodilation (FMD) is a non-invasive ultrasound method of evaluating endothelial function. Methodological choices and operator experience may affect results. A systematic approach to FMD in human studies is discussed here.
FAQs
Nitric oxide–cGMP signaling relaxes vascular smooth muscle by activating a pathway that promotes vessel relaxation. As vessels widen, vascular resistance falls, which can improve blood flow and reduce cardiovascular workload. This mechanism is especially relevant when treatment aims to alter resistance through smooth-muscle control rather than through reduced stimulation of vasoconstrictor receptors alone.
Calcium-channel inhibition limits a signal required for vascular smooth-muscle contraction, while reduced stimulation of vasoconstrictor receptors decreases receptor-driven narrowing. Both mechanisms can promote vessel relaxation, but they act at different points in the contraction process. Recognizing this distinction helps pharmacologists relate a drug’s molecular action to its effect on vascular resistance and blood flow.
Preload and afterload represent different pressures placed on the heart, so reducing either can change cardiac workload in a different way. Vasodilation therapy may decrease afterload or preload, depending on its vascular effects. This distinction matters when the treatment goal is to lower the heart’s workload while still improving perfusion and avoiding excessive cardiovascular compromise.
The therapeutic rationale differs across these conditions, although lowering vascular resistance can be important in each. In hypertension, reducing resistance can lower pressure; in angina, improved blood flow may support tissue perfusion; and in heart failure, reducing preload or afterload may lessen cardiac workload. These outcomes guide the clinical use of pharmacological vasodilators.
Systemic and pulmonary vascular disorders involve different vascular territories, making treatment selection dependent on where the abnormal resistance or perfusion problem occurs. Vasodilation therapy provides a framework for targeting vascular relaxation in either setting. Understanding the relevant territory helps clinicians connect a drug’s mechanism with the intended change in blood flow, resistance, or cardiac workload.
Excessive vascular relaxation can produce hypotension, while vascular changes may also cause headache or reflex tachycardia. These effects can offset the intended reduction in cardiac workload or create additional cardiovascular stress. Clinicians therefore balance improved perfusion and reduced preload or afterload against blood-pressure lowering and compensatory responses when evaluating treatment outcomes.